DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 94 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Omaxe Limited — Acquisition

NSE 1 hr ago·26 Oct 2026, 4:18 pm

Omaxe

Omaxe Limited has announced the formation of a new wholly-owned subsidiary. This entity is being created to facilitate the company's strategic business operations and future growth plans.

This move is significant for investors as it signals Omaxe's intent to diversify and streamline its business structure. By creating a dedicated subsidiary, the company can manage specific projects or ventures more efficiently, potentially unlocking new value for shareholders.

Investors should monitor the specific objectives of this new subsidiary. Understanding its role in Omaxe's broader strategy will be key to assessing the long-term impact on the company's performance and market position.